Estadístiques de Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations
Visites totals
| views | |
|---|---|
| Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations | 153 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| sans-ijn-tova.pdf(legacy) | 199 |
| sans-ijn-tova.pdf | 27 |
Vistes principals per país
| views | |
|---|---|
| United States | 139 |
| Germany | 4 |
| Belgium | 3 |
| Spain | 2 |
| Australia | 1 |
| Canada | 1 |
| France | 1 |
| Malaysia | 1 |
| Sweden | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Ashburn | 42 |
| San Ramon | 22 |
| Fairfield | 21 |
| Boardman | 13 |
| Cambridge | 6 |
| Mountain View | 6 |
| Ann Arbor | 5 |
| Jacksonville | 2 |
| Menlo Park | 2 |
| Redwood City | 2 |
| San Mateo | 2 |
| Barcelona | 1 |
| Calgary | 1 |
| Fremont | 1 |
| Magdeburg | 1 |
| Premiá De Mar | 1 |
| San Jose | 1 |
| Shah Alam | 1 |
| Sydney | 1 |